Endometrial biopsy during hormone replacement cycle in donor oocyte recipients before in vitro fertilization-embryo transfer

Our purpose is to explore whether anti-dsDNA antibody, which was demonstrated to enter living cells and induced apoptosis, could adversely affect reproductive outcomes. A total of 259 women receiving the in vitro fertilization-embryo transfer (IVF) cycle were enrolled in this study, including 52 women with positive ANA and anti-dsDNA (ANA+/anti-dsDNA+ group), 86 women with positive ANA and negative anti-dsDNA (ANA+/anti-dsDNA− group), and 121 women with negative ANA and anti-dsDNA (ANA−/anti-dsDNA− group). 136 nonpregnant women among 259 patients in the IVF-ET cycle were enrolled in the hormone replacement therapy frozen-thawed embryo transfer (HRT-TET) cycle. We compared basic characters and IVF outcomes among three groups in fresh embryo transfer and frozen-thawed embryo transfer cycle, respectively. The number of retrieved oocytes, available embryos, and high-quality embryos in the ANA+/anti-dsDNA+ group was lower than those in the other two groups in the fresh embryo transfer cycle. The rates of fertilization, implantation, and clinical pregnancy in the ANA+/anti-dsDNA+ group were the lowest, while the early miscarriage rate was the highest in the ANA+/anti-dsDNA+ group both in the fresh embryo transfer cycle and in the frozen-thawed embryo transfer cycle. Our data suggested that anti-dsDNA antibody may be the essential marker for defective oocytes or embryos in infertile women with any type of ANA.

Download Full-text

The effectiveness of different protocols of preparation of the endometrium when transferring vitrified/warmed embryos

HEALTH OF WOMAN ◽

10.15574/hw.2017.118.30 ◽

2017 ◽

pp. 30-32

Author(s):

V.Y. Parashchuk ◽

◽

A.S. Lutsky ◽

N.G. Gryshchenko ◽

◽

...

Keyword(s):

Hormone Replacement Therapy ◽

In Vitro Fertilization ◽

Replacement Therapy ◽

Embryo Transfer ◽

Ovarian Hyperstimulation Syndrome ◽

Hormone Replacement ◽

Implantation Rate ◽

Vitro Fertilization ◽

Frozen Embryos

Currently, there is a tendency toward increasing usage of criocycles in programs of in vitro fertilization. This approach allows to achieve pregnancy as well as prevent the development of ovarian hyperstimulation syndrome and utilize the pre-implantation genetic diagnostics. The objective: to improve the efficiency of in vitro fertilization treatment cycles with transferring of cryopreserved/warmed embryos into the uterus. Patients and methods. The study of 824 treatment cycles (in natural menstrual cycle, in cycle with hormone replacement therapy, after egg donation, in natural cycle without embryo transfer in «fresh» cycle, in cycle with hormone replacement therapy without embryo transfer in «fresh» cycle). Vitrification and cryopreservation method. Results. The analysis of the study results has shown that the implantation rate of frozen embryos in the natural cycle is higher than in the cycle with hormone replacement therapy. The implantation rate of frozen embryos after the use of agonist gonadotropin-releasing hormone as a trigger of final maturation of the agonist is higher than that of human chorionic gonadotropin, which allows us to consider vitrification as an effective tool that provides great flexibility of conducting controlled ovarian stimulation cycles and prevention of ovarian hyperstimulation syndrome. Conclusion. The effectiveness of frozen embryo transfer protocols gives us grounds to assert that the optimum cycle for the transfer is a cycle without stimulation. Key words: in vitro fertilization, the endometrium, frozen embryo implantation.

Download Full-text